Drugs Made In America Acquisition Corp. - Ordinary Shares, $0.0001 par value (DMAA)

Historical Holders from Q1 2025 to Q3 2025

Symbol
DMAA on Nasdaq
CUSIP
G2847J104
Type / Class
Equity / Ordinary Shares, $0.0001 par value
Shares outstanding
33.5M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
22.4M
Holdings value
$230M
% of all portfolios
0.001%
Grand Portfolio weight change
+0%
Number of holders
38
Number of buys
16
Number of sells
-14
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Drugs Made In America Acquisition Corp. - Ordinary Shares, $0.0001 par value (DMAA)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Drugs Made In America Acquisition LLC 12.5% $42M 4.19M Drugs Made In America Acquisition LLC Feb 18, 2025
Karpus Management, Inc. 8.19% +18% $28.2M $4.31M 2.74M +18.1% KARPUS MANAGEMENT, INC. Jun 30, 2025
First Trust Capital Management L.P. 6.17% $20.7M 2.07M First Trust Capital Management L.P. Mar 31, 2025
Polar Asset Management Partners Inc. 5.7% $19.1M 1.9M Polar Asset Management Partners Inc. Mar 31, 2025
GLAZER CAPITAL, LLC 5.44% $18.3M 1.82M Glazer Capital, LLC Mar 31, 2025
Hudson Bay Capital Management LP 4.62% -15% $15.9M -$2.57M 1.55M -13.9% Hudson Bay Capital Management LP Sep 30, 2025

Institutional Holders of Drugs Made In America Acquisition Corp. - Ordinary Shares, $0.0001 par value (DMAA)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 22.4M $230M +$8.65M $10.27 38
2025 Q2 20.8M $212M +$35.8M $10.20 32
2025 Q1 16.9M $170M +$170M $10.02 23